NOX4 and pulmonary arterial hypertension: In another mouse model, chronic intermittent hypoxia (CIH)-induced pulmonary hypertension is associated with increased lung levels of the NOX4 and p22phox, reduced NO bioavailability, increased activity of platelet-derived growth factor receptor β (PDGFRβ) and downstream effector, Akt kinase [44].